Varlilumab Biosimilar

REQUEST MORE INFO
Catalogue No: abx831311
Price: US$435.00
(Size: 100 µg)

Orders to United States ship from United States

Click on the image to see the image legend

Available Options

* Size:




Add to Cart Buy It Now GET A QUOTE

Documents

Datasheet SDS
Varlilumab is a fully Human monoclonal antibody biosimilar expressed in CHO cells, targeting CD27/TNFRSF7, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications.

Varlilumab has been used in trials studying the treatment of MELANOMA, Skin Ulcer, Burkett's Lymphoma, Mantle cell lymphoma, and Any T-cell Malignancy, among others.

Target CD27/TNFRSF7
Research Area Biosimilars
Clonality Monoclonal
Reactivity Human
Expression Recombinant
Tested Applications ELISA
Host Human
Recommended dilutions Optimal dilutions/concentrations should be determined by the end user.
Conjugation Unconjugated
Isotype IgG1 Kappa
Form Liquid
Purity > 95%
Purification Purified from cell culture supernatants by Protein A/G chromatography.
Storage Store at 4°C for up to 2 weeks. Aliquot and store at -20°C for long term storage. Avoid repeated freeze/thaw cycles.
Shelf Life 12 months.
Buffer 0.01 M PBS, pH 7.4.
CAS Number 1393344-72-3
Concentration Batch-dependent, typically between 0.5-2.0 mg/ml.
Availability Shipped within 5-10 working days.
Note THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
Research Articles on CD27/TNFRSF7


Write a review

Tags:
(Click to show)